Sunday, 25 October 2020

The Immunoprecipitation Market World Leading Key Players Revenue, Share, Analysis And Estimation Till 2023

 Market Highlights

It is estimated that the global immunoprecipitation market growth is expected to hold a market value of USD 562 million and register a CAGR ~ 5.2% during the forecast period of 2018–2023. The method of precipitating a protein antigen from a solution by using an antibody that exactly binds to that particular protein is known as immunoprecipitation. This technique can be used for isolation and concentration of a particular protein from a sample that contains thousands of different proteins. A growing number of research activities in the life sciences sector and rising need to identify antigens associated with autoimmune diseases are driving the market growth. According to a report published by the British Society of Immunology in March 2016, more than 80 autoimmune diseases have been identified. Furthermore, increasing investments by governments and industries, rising biotechnology research across the globe, and growing awareness about personalized therapeutics is fueling the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7816 

However, the presence of alternative technologies for protein purification may negatively affect market growth during the forecast period.

The global immunoprecipitation market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in January 2018, Abcam plc entered into a strategic agreement with F. Hoffmann-La Roche Ltd, a leading biotech company, under which Abcam received the exclusive rights to the product portfolio of Spring, that consists of 243 recombinant rabbit monoclonal antibodies and 500 additional antibody products.

Regional Analysis

Americas is anticipated to dominate the global immunoprecipitation market owing to the increasing research activities and the presence of major market players. Additionally, the well-developed healthcare sector is anticipated to boost the immunoprecipitation market in the region.

Europe is expected to hold the second largest position in the global immunoprecipitation market. The market growth in this region is attributed to the availability of funds for research.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the growing investment from governments, growing biotechnology research in these regions, and raising awareness about personalized therapeutics.

On the other hand, the Middle East & Africa is expected to account for the least share of the market.

Segmentation

The global immunoprecipitation market has been segmented into type, product, end-user, and region.

The market, on the basis of type, has been segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, and RNA immunoprecipitation.

The market, by type, has been segmented into kit, reagent, and others.

The market, based on reagent, has been further segmented into antibodies and beads. Antibodies are further segmented into primary and secondary. Beads are further segmented into agarose beads, magnetic beads, and buffers.

The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.

Key Players

Some of the key players in the global immunoprecipitation market are Abcam plc, GenScript, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Merck KGaA, BioLegend, Inc., Takara Bio Inc., Rockland Immunochemicals Inc., Cell Signaling Technology, Inc., Geno Technology Inc.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/immunoprecipitation-market-7816 


The Dental Industry Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 

Market Highlights

The dental industry includes the diagnosis, treatment, instruments, and devices related to oral health. There are various problems related to oral health such as pigmentation in gums, teeth cavity, brown or discoloration of teeth and others which are treated under the dental, medical industry. The key factors driving the dental industry include rising aging population globally, growing demand for cosmetic dentistry treatments, and increasing demand for dental procedures.

However, factors such as low dental insurance coverage compared to general health, lack of technological awareness and grey market of dental products, hinder the market growth. The market for the global dental industry market size is estimated to grow at an approximate CAGR of 7.6% from 2018 to 2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7637 

Segmentation

The global dental industry market is segmented on the basis of discipline, consumables and end users. On the basis of the discipline, the market is categorized into restorative dentistry, endodontics, prosthodontics, orthodontics, periodontics, and oral surgery.

On the basis of consumables, the global dental industry market is segmented into dental burs, whitening material, dental biomaterial, gingival retraction material, dental anesthetic, dental syringe, and endodontic supplies. The dental biomaterial segment is sub-segmented into dental cement, dental bone graft and regenerative tissue material. The gingival retraction material is further sub-segmented into gingival hemostatic agents, gingival retraction cord and gingival retraction paste/gels/cap. The dental anesthetic is further sub-segmented into topical anesthetics, injectable anesthetic, and non-injectable anesthetic. The dental syringe is sub-segmented into a non-disposable syringe and disposable syringes/ safety syringes. The endodontic supplies are sub-segmented into files and cement. On the basis of the end-user, the market is segmented into dental hospitals & clinics, dental institutes and dental academic and research institutes.

On a regional basis, the global dental industry market in the Americas is segmented into two major regions, i.e., North America and Latin America. The North American region is likely to hold the major share in the global dental industry market owing to the presence of well-established healthcare sector, growing prevalence of dental problems and also high disposable income. Additionally, the Asia-Pacific region is anticipated to be the fastest growing region due to the rising awareness about treatment and increasing healthcare facilities provides a favourable scenario for market growth.

Regional Analysis

The Americas dominate the global dental industry market owing to the increasing prevalence of fungal infection in the mouth, growing demand for cosmetic dentistry treatments and a huge patient population suffering from oral diseases across the Americas. According to the Centers for Disease Control and Prevention the US oral and dental health data 84.6% of children aged 2-17 years have a dental visit in the US in 2016 which increase the dental industry in this region.

Moreover, rising healthcare expenditure and the presence of developed economies like the US and Canada fuel the market growth.

Europe is second in the global dental industry market owing to a huge number of children’s suffering oral problems, increasing geriatric population, and presence of the developed economies like the UK, Italy, France, and others.  Asia-Pacific region is the fastest growing market owing to the presence of developing economies, a growing healthcare sector and rising geriatric population drive the market with the region. The Middle East & Africa has the least share in the global dental industry market owing to the presence of poor economies and stringent government policies, especially in the African region.

Key Players

Henry Schein Inc., Hu-Friedy Mfg Co., Ivoclar Vivadent AG, Nakanishi Inc., Patterson Companies Inc., Dentsply Sirona, Ultradent Products Inc., Young Innovations Inc., and 3M Company, Zimmer Biomet, Kangda Medical are some of the major players for global dental industry market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-industry-market-7637 


The Urinary Catheters Market World Leading Key Players Revenue, Share, Analysis And Estimation Till 2023

 

Market Highlights

The global urinary catheters market held a market value of USD 1,103 million in 2017 and is projected to grow at a CAGR of 7.8% over the forecast period. 

The increasing prevalence of chronic renal diseases across the globe is one of the major factors for increasing the demand for urinary catheters. According to the International Agency for Research on Cancer, 430,000 new cases of bladder cancer was registered in 2012. Due to rapid economic growth, increasing spending on healthcare, and government support to provide affordable medical facilities to the public are major factors that are driving the demand for urinary catheters in this market. Emerging markets are showing tremendous growth rate in all segments of the healthcare sector. Top players are focusing on this region and investing a large amount of money for research, new product development and business expansion due to its high growth potential. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7600 

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global urinary catheters market owing to the growing R&D budgets by both governments as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region.    

Europe is expected to hold the second largest position in the global urinary catheters market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Asia-Pacific is witnessing the fastest growth rate in global urinary catheters market. This fast growth is expected due to; rapidly developing healthcare sector, changing healthcare practices, rapid urbanization, rising healthcare expenditure, and increasing prevalence of urologic diseases. Lack of safe drinking water is leading to various chronic diseases in this region. According to the World Health Organization, around 600 million people in this region don’t have access to an improved source of drinking water. Government and NGOs are taking various initiatives like providing subsidies, affordable healthcare, and awareness programs are another important factor for the growth of the Asia-Pacific urinary catheters market. In India, the government is providing affordable insurance to the common public. The Indian government is also planning a public-private partnership to improve public healthcare facilities. Australia announces an investment of USD 5.25 million for R&D and clinical trials. India encouraging research by exempting academic institutions from the requirement of compulsory permission from government agencies for clinical trials.  

The Middle East & Africa has the least share of the global urinary catheters market.  Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

Key Players

Some of the prominent players in the global urinary catheters market manufacturers are Boston Scientific Corporation, Coloplast A/S, ConvaTec Group PLC, Werkomed Pty Ltd, B. Braun Melsungen AG, DISA Vascular, Medloyd Healthcare, Terumo Europe NV, Teleflex, Medtronic, C.R. Bard, Inc., Wellspect Healthcare (A Subsidiary of Dentsply IH Ltd.), Bactiguard Holding, Cook Medical, Hollister Incorporated, Rochester Medical Corporation, and others.

Segmentation

The global urinary catheters market has been segmented into type, product, gender, indication, and end user. 

By type, the market has been segmented into coated catheters and uncoated catheters.

Based on product, the market has been segmented into Intermittent catheters, indwelling catheters, and external catheters.

The market, by gender, has been segmented into male urinary catheters and female urinary catheters.

The market, by indication, has been segmented into benign prostatic hyperplasia, spinal cord injuries,

urinary incontinence, and general surgery.

The market, by end user, has been segmented into hospitals & clinics, research organization & academic institutes, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/urinary-catheters-market-one-7600 

 

Worldwide Solid Phase Extraction Market Segmentation And Analysis By Recent Trends And Growth Prospects By Regions To 2023

 

Market Highlights

The global solid phase extraction market growth is expected to register a CAGR of 4.62% to reach USD 474.73 million till 2023. Solid phase extraction (SPE) is a sample preparation process by which compounds that are dissolved or suspended in a liquid mixture are separated from other compounds in the mixture according to their physical and chemical properties.

Technological advancements in instrumentation, rising government investments in academics and life sciences, and high growth in the generic pharmaceutical market and contract research organizations (CRO are responsible for the growth of the global solid phase extraction industry market in the recent years. However, costs related to instruments and unfavorable government policies and regulations are likely to restrain the market growth over the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7552

Segment analysis

The global solid phase extraction industry market has been divided into segments, namely, type and application. Based on type, the market has been classified into SPE disk and SPE cartridge. Based on application, the global solid phase extraction industry market is segmented into pharmaceutical industries, hospitals and clinics, and environmental care.

Regional Analysis

Geographically, the Americas is expected to dominate the global solid phase extraction industry market. This is owing to the growing use of solid phase extraction technology in various industries such as pharmaceutical, biotechnology, agriculture, and others. Asia-Pacific is estimated to be the fastest growing region in the market. Latest progression in instrumentation, emerging economic conditions, increasing investment in biotechnology, and pharmaceutical research organizations in developing countries of Asia-Pacific are expected to contribute to the increasing demand for solid phase extraction products. In 2017, South Korea accounted for a market share of 15.9% in the Asia-Pacific solid phase extraction industry market. On the other hand, the Middle East and Africa has the least share of the market due to the low disposable income.

Key Findings of the Study

  • The global solid phase extraction industry market is projected to reach USD 474.73 million by 2023 at a CAGR of 4.62% during the review period of 2018-2023
  • The Americas accounted for the largest share due to the increasing use of solid phase extraction products in the life sciences industry in the region
  • The pharmaceutical industries segment accounted for the largest share, holding a market value of USD 109.01 million in 2017.
  • Some of the players operating in the solid phase extraction industry market are Thermo Fisher Scientific Inc, PerkinElmer Inc, 3M, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/solid-phase-extraction-market-7552


Neonatal Intensive Care Market Sparkling Growth Worldwide Forecasts By 2023

 

Market Highlights

It is estimated that the global neonatal intensive care market is expected to register a CAGR ~5.5% during the forecast period of 2018–2023 with an estimated market value of 9.1 billion in 2017.

The global market is driven by factors such as rising prevalence of diseases in new-born children and increasing neonatal population. According to data published by the Centers for Disease Control and Prevention in January 2017, there were 3,945,875 births in the US in 2017.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7513

On the other hand, the lack of awareness, high cost of equipment, and lack of skilled professionals is restraining the growth of neonatal intensive care market. For instance, according to a report published by the International Journal of Neonatal Screening in September 2018, the reports of false positive cases in neonates are increasing for various diseases.

The global neonatal intensive care unit equipment market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, PerkinElmer’s QSight 210 MD system launched in September 2016, utilizes tandem quadrupole analysis which provides regular robust screening along with higher sensitivity and faster scanning.

Regional Analysis

The market in the Americas is expected to dominate the global Neonatal Intensive Care market during the forecast period. The rising prevalence of congenital disorders in new-born, increasing neonatal population and government support are driving the growth of the market in the Americas. According to a data published by the Centers for Disease Control and Prevention (CDC) in November 2018, congenital heart defects (CHDs) affect approximately 1% or about 40,000 births per year in the US.

Europe showed a considerable amount of growth in the global neonatal intensive care market. The market growth in this region is because of the presence of a well-established healthcare system and increase in insurance coverage for pets. Also, technological advancements in the industry and government support in terms of National Health Service and health insurance are expected to drive the market growth.

Asia-Pacific is estimated to be the fastest growing region in the market due to increased pet adoptions and rise in the number of animal welfare programs.

On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income. According to the American Society of Hematology (ASH), it led a campaign to fight sickle cell disease in Africa in June 2018. It also urged the governments, particularly in sub-Saharan Africa, to invest in new-born intensive care units for the betterment of the neonates.

Segmentation

The global neonatal intensive care market has been segmented into product, and end user. The market, based on product, has been segmented into infant warmers, incubators, respiratory devices, neonatal monitoring devices, convertible warmer & incubators, phototherapy equipment, catheters, and others. The market, by infant warmers, has been segmented into electric infant warmers, and non-electric infant warmers. The market, by neonatal monitoring devices, has been sub-segmented into cardiopulmonary monitor, blood pressure monitor, pulse oximeters, capnographs, and others. The market, by end user, has been segmented into hospitals, childcare clinics, and others.

Key Players

Some of the key players in the global neonatal intensive care market are B. Braun Melsungen AG, DRE Medical, Digicare Biomedical Technology Inc., Henry Schein, Jorgensen Labs, Medtronic, Midmark Corporation, Patterson Companies, Inc., Smiths Group plc, and Vetland Medical Sales & Services.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/neonatal-intensive-care-market-7513 


The Medical Carts Market World Leading Key Players Revenue, Share, Analysis And Estimation Till 2023

 

Market Highlights

The growing acceptance of medical carts accustomed by its technical advances is one of the major trends witnessed in the global medical computer carts market over the forecast period.

According to world health organization, musculoskeletal conditions are the second largest contributor to disability globally. Musculoskeletal conditions include conditions that affect joints (psoriatic arthritis, gout, osteoarthritis, rheumatoid arthritis), bones (osteoporosis, osteopenia and associated fragility fractures), and muscles (sarcopenia).

Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as high cost of advanced medical carts in developing countries, is likely to curb the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7436 

Segmentation

The global medical carts market is segmented based on product type, type, material type, and end-users.

The medical carts market, by product type, the market is segmented into mobile computing carts, medical storage columns, wall-mounted workstations, medication carts, and others.

Based on type, the market is segmented into computer medical cart, procedure cart, emergency cart, anaesthesia cart, and others.

Based on material type, the market is segmented into metal type, plastic type, and others.

 Based on end-user, the market is segmented into hospitals and clinics, ambulatory surgical centres, and others.


Regional Analysis

The Americas is the largest in the market owing to the improving research infrastructure in the region, coupled with the rising awareness among patients and physicians. It is currently exhibiting a highly lucrative growth rate due to an increased use of medical carts for various applications. 

The European region is the second largest medical carts market over the forecast period due to high acceptance of medical carts in developing countries along with the rising incidence of chronic diseases are also accountable for the growth of the medical carts market.   

The Asia Pacific region is likely to develop at the uppermost CAGR for the medical carts market in the years to come. Moreover, the rising patient safety at the hospitals and at community level are expected to influence the market in a positive way.

The Middle East and Africa accounts for the least market share due to low per capita income and lack of availability of well-trained healthcare professionals. 

Key Players

Some of the key players in the global medical carts market are ITD GmbH (Germany), Advantech Co. (Taiwan) Ltd, Harloff Manufacturing Co. (US), AFC Industries (US), Chang Gung Medical Technology Co. (Taiwan), Omnicell Inc. (US), Midmark Corporation (US), The Bergmann Group (US), Capsa Healthcare (US), Jaco Inc (US), Waterloo Healthcare (US), Ergotron Inc (US) and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/medical-carts-market-7436 


World Advanced Wound Therapy Devices Market Top Key Players Shares, Revenue, Analysis And Forecasts To 2023

 

Overview:

The global advanced wound care therapy devices market is anticipated to touch a value of USD 2,804.53 million by 2023, asserts Market Research Future (MRFR). The market can showcase 6.70% CAGR from 2018 to 2023 (forecast period).

Increasing incidence of diabetes is the primary driver of the market. Patients with diabetes have a slower healing rate and poor blood circulation which can negatively affect the immunity system. According to the Centers for Disease Control & Prevention (CDC), nearly 30.3 million in the U.S. suffer from diabetes. The advanced wound therapy devices market can expand by capitalizing on this trend and offering precise solutions.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7421 

The growing numbers of the geriatric populace will be highly beneficial to the market. This is buttressed by the estimation by the World Health Organization (WHO) which pegs the elderly populace at 1.2 billion by 2025. Furthermore, development of novel products and rapid approval by regulatory bodies is projected to propel the advanced wound therapy devices market. For instance, ConvaTec got approval for its negative pressure wound therapy (NPWT) system by the U.S. FDA in 2018. The hydrofiber gels in the system lock the exudates and bacteria and offer a separate channel for the them to flow away from the wounded region.

Segmentation Analysis: 

The advanced wound therapy devices market is segmented by type and end-user.

By type, negative pressure wound therapy systems accounted for 42.9% share in 2017, followed by pressure relief devices (28.2%), hyperbaric oxygen equipment (15.2%), electric stimulation devices (7.9%), and others (5.8%). Negative pressure wound therapy systems can attain revenue close to USD 1,217.41 million by 2023 at 6.91% CAGR over the forecast period. But pressure relief devices are projected to experience the highest CAGR of 7.03% during the assessment period to accrue close to USD 805.35 million by 2023.

Among end-users, hospitals & clinics accounted for 73.7% share in 2017, followed by home care settings (14.5%), and others (11.8%). Hospitals & clinics can register close to 6.95% CAGR during the forecast period to generate close to USD 2,095.66 million by 2023. On the other hand, the home care settings segment is expected to exhibit 6.78% CAGR to touch a size of USD 408.50 million by the end of the forecast period.

Regional Analysis:

Region-wise, the advanced wound therapy devices market is segmented into Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA).

The Americas are anticipated to reign as the leading region of the market owing to a mix of attractive reimbursement schemes, numerous treatment options, and prevalence of diabetes and chronic wounds. The region can accumulate close to USD 993.07 million by 2023 at 6.11% CAGR over the forecast period.

The European region is touted to register a notable growth rate owing to awareness of chronic wounds, rise in government initiatives, and awareness among healthcare providers. Presence of reputed companies such as Lohmann & Rauscher and technological advances of products can drive the regional advanced wound therapy devices market growth. The region can accrue close to USD 924.85 million by 2023 at 7.02% CAGR over the forecast period.

The APAC region is expected to be extremely lucrative for the advanced wound therapy devices market. This can be credited to high number of burn injury cases and awareness of NPWT devices. It can attain a size of USD 676.27 million by 2023 at 7.16% CAGR over the assessment period.

Competitive Analysis:

Notable player names in the advanced wound therapy devices market are Cardinal Health (U.S.), ConvaTec Inc. (U.K.), Smith & Nephew plc (U.K.), Triage Meditech Pvt. Ltd. (India), Medela AG (Switzerland), Sechrist (U.S.), Mölnlycke Health Care AB (Sweden), B. Braun Melsungen AG (Germany), DeRoyal Industries, Inc. (U.S.), Lohmann & Rauscher GmbH & Co. KG (Germany), Perry Baromedical (U.S.), and KCI Licensing, Inc. (U.S.).

Browse Complete Report @ https://www.marketresearchfuture.com/reports/advanced-wound-therapy-devices-market-7421